KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
RemedyX Labs: 26 Kovera certificates.
The lab's record shows 26 certificates printed for RemedyX Labs, analysed between 19 Mar 2026 and 25 May 2026, covering 17 products. Median HPLC purity is 99.90%. Kovera graded 21 as a pass and 0 as a fail; 5 carry no verdict.
26
certificates
99.90%
median purity
17
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 26 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 7 measured more than 110% of the label, which Kovera does not grade as a fail.
Kovera prints this client as "REMEDYX LABS" and "RemedyX Labs". We count them as one name because they differ only in capitals or spacing.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
17 AS PRINTEDRXL-2TRZ · 3RXL-3RT · 3BPC-157 · 2CJC-1295 (No DAC)/Ipamorelin · 2GLP-R3 · 2GLP-T2 · 2NAD+ · 2Bacteriostatic Water · 1BPC-157/TB-500 · 1GHK-Cu · 1Glow · 1Ipamorelin · 1Melanotan-2 · 1MOTS-c · 1Selank · 1Semax · 1TB-500 (Thymosin B4) · 1
Every certificate
NEWEST FIRST · 26 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| BAC-KVR-2026-8A7DBD | Bacteriostatic Waterbac water certificate | RMXL-26BAC10-001 | — | — | 25 May 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-950F06 | CJC-1295 (No DAC)/Ipamorelin | RMXL-26CIP-26 | 99.898% | 117.5%11.75 of 10 mg | 24 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-867F38 | BPC-157 | RMXL-26B-19 | 99.397% | 100.4%10.04 of 10 mg | 24 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-86672E | GHK-Cu | RMXL-26G-27 | 98.976% | 108.2%108.25 of 100 mg | 24 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-0C1F0E | NAD+ | RMXL-26N-22 | 99.544% | 102.7%513.25 of 500 mg | 24 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-F7EE46 | Semax | RMXL-26SMX-01 | 99.853% | 108.4%10.84 of 10 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-E12014 | TB-500 (Thymosin B4) | RMXL-26TB-24 | 99.949% | 123.3%12.33 of 10 mg | 26 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C82A04 | Ipamorelin | RMXL-26I-26 | 99.906% | 106.7%10.67 of 10 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-C7A951 | RXL-3RT | RMXL-26R-19 | 99.906% | 110.2%11.02 of 10 mg | 26 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B50A66 | MOTS-c | RMXL-26M-23 | 99.826% | 114.4%11.44 of 10 mg | 26 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-897ECB | BPC-157 | RMXL-26B-20 | 99.921% | 92.1%9.21 of 10 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8394B7 | Glow | RMXL-26BBG-01 | 99.766% | 108.3%75.81 of 70 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-5F90C9 | BPC-157/TB-500 | RMXL-26BT-01 | 99.754% | 107.0%21.4 of 20 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-59ED60 | CJC-1295 (No DAC)/Ipamorelin | RMXL-26CIP-25 | 99.831% | 107.5%10.75 of 10 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-3A6E64 | RXL-3RT | RMXL-26R-20 | 99.879% | 112.1%33.64 of 30 mg | 26 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-37B964 | RXL-2TRZ | RMXL-26T-16 | 99.904% | 106.1%31.82 of 30 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-35D832 | Selank | RMXL-26SEL-01 | 99.947% | 111.7%11.17 of 10 mg | 26 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-338240 | RXL-2TRZ | RMXL-26T-15 | 99.812% | 116.6%11.66 of 10 mg | 26 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8D6938 | Melanotan-2 | RMXL-26M-20 | 99.987% | 105.1%10.51 of 10 mg | 8 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-9BFDF8 | RXL-3RT | RMXL-26R-18 | 99.927% | 106.0%31.81 of 30 mg | 7 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-382C36 | RXL-2TRZ | RMXL-26T-14 | 99.934% | 107.5%64.48 of 60 mg | 7 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8D024E | GLP-R3 | RMXL-26R-16 | — | — | 30 Mar 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-9C7886 | GLP-R3 | RMXL-26G-17 | — | — | 29 Mar 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-6D880D | GLP-T2 | RMXL-26T-13 | — | — | 29 Mar 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-43E23D | GLP-T2 | RMXL-26T-12 | — | — | 29 Mar 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-71A3D8 | NAD+ | RMXL-26N-21 | 99.983% | 105.3%526.39 of 500 mg | 19 Mar 2026 | PASS | Kovera ↗our verifier → |